Johnson & Johnson (NYSE:JNJ) is one of the best stocks for beginners to buy now. On June 11, Johnson & Johnson expanded the ...
Johnson & Johnson (NYSE: JNJ) is expanding the U.S. roll-out of its latest advancement in presbyopia-correcting intraocular lenses (PC-IOLs). TECNIS PureSee IOL is an extended depth of focus (EDOF) ...
Johnson & Johnson (JNJ) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved its Tecnis PureSee intraocular lens (IOL), giving eye surgeons a new lens option for use in ...
Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract ...
New Delhi: Johnson & Johnson (J&J) has introduced the TECNIS PureSee, a purely refractive intraocular lens (IOL) designed for individuals with presbyopia, in India. The TECNIS PureSee IOL delivers ...
AUSTIN, TX, UNITED STATES, April 2, 2026 /EINPresswire.com/ — Dell Laser Consultants is proud to be among the first practices in the United States to offer the ...
The historical paradigm of cataract surgery forced an absolute compromise: pristine distance vision with absolute spectacle ...
Please provide your email address to receive an email when new articles are posted on . The presbyopia-correcting Tecnis PureSee IOL is now fully available in the U.S. The company launched a patient ...
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) is expanding the U.S. roll-out of its latest advancement in presbyopia-correcting intraocular lenses (PC-IOLs). TECNIS PureSee IOL is ...
J&J expands US availability of TECNIS PureSee IOL; an advanced lens option for cataract surgeons and patients: Jacksonville, Florida Saturday, June 13, 2026, 15:00 Hrs [IST] Johns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results